Ai In Healthcare Governance And Safety Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

The market encompasses governance, risk, and compliance (GRC) tooling purpose-built for AI systems used in diagnosis, treatment planning, imaging, drug discovery, and hospital operations, together with broader patient-safety oversight functions. With a 2026 base of roughly USD 2.962 billion and a 23.4% compound annual growth rate, the segment is one of the fastest-growing sub-categories of the wider healthcare AI software market, which itself reached approximately USD 39 billion in 2025. Because no official government statistical agency publishes dedicated sizing for this niche, current figures are derived from industry analyst estimates that track vendor revenues, deployment counts, and regulatory disclosures.

Three forces are accelerating adoption: rising clinical AI deployment, a tightening global regulatory environment, and growing institutional accountability for algorithmic harm. The EU AI Act classifies most clinical AI as high-risk, while the U.S. FDA has issued guidance on predetermined change control plans and lifecycle management for AI/ML-enabled medical devices, both pushing hospitals and vendors to formalize governance. Concurrently, documented incidents of racial and gender bias in healthcare algorithms and increasing HIPAA and GDPR scrutiny are forcing boards and compliance teams to invest in monitoring and audit infrastructure.

The market is typically segmented by component (software platforms, services, and consulting), by deployment (cloud and on-premise), and by end user (hospitals and health systems, payers, pharmaceutical companies, and medical device manufacturers). North America leads on the back of large hospital systems, mature compliance functions, and active FDA engagement, while Europe is the fastest-growing region due to the EU AI Act's binding requirements. Asia-Pacific is expanding quickly as national health systems in China, India, Japan, and Singapore scale AI deployment alongside new data-protection regimes.

What are the recent trends and outlook?

Through 2031 the market is expected to shift from point solutions toward integrated governance platforms that combine model inventory, bias and drift monitoring, regulatory reporting, and clinical risk dashboards in a single workflow. Generative AI is becoming a new governance priority because large language models in clinical documentation and triage introduce novel hallucination, privacy, and liability risks. With a projected CAGR of roughly 23.4%, the addressable opportunity is set to multiply several times over the period as AI governance moves from a compliance checkbox to a core clinical-safety function.

Named companies and quantified developments shaping the Ai In Healthcare Governance And Safety Market market.

• •FDA - The FDA's Predetermined Change Control Plan, finalized in August 2025, allows vendors to ship software updates without fresh submissions if ongoing drift and performance dashboards remain within approved bounds.
• •AI in healthcare governance and safety market - The AI in healthcare governance and safety market size is expected to grow from USD 188.85 million in 2025 to USD 220.37 million in 2026 and is forecast to reach USD 552.30 million by 2031 at a 20.17% CAGR over 2026-2031.